ghk cu tripeptide 5 mg GHK-Cu Copper Tripeptide-1 GHK-Cu 50mg $31.99/Vial 99% Pure

The specific volume recommended for your peptide product will be outlined by your healthcare provider based on your prescribed dosing protocol

Some patients report mild side effects such as nausea, headaches, fatigue, dizziness, or injection site irritation

Retatrutide needs additional TRIUMPH trial results throughout 2026 before submitting for FDA approval in late 2026 or early 2027, with approval expected in late 2027 and launch in early 2028

Product Usage: For Research Use Only Not for Human or Veterinary Use Pure Health Peptides products are supplied to qualified research professionals and institutional users for in vitro laboratory research only